VERU INC. Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
VERU INC. (VERU) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $0 as of 2015-03-31, per its 10-Q filed 2015-04-30.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2015-04-30
- 2015-03-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2014-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2014-09-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2014-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2015-03-31 | $0.00 10-Q · filed 2015-04-30 |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-03 |
| 2014-09-30 | $0.00 10-Q · filed 2015-04-30 |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-31 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-01 |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-03 |
| 2013-09-30 | $0.00 10-K · filed 2014-12-02 |
| 2012-09-30 | $0.00 10-K · filed 2013-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |